However, the role of IL-17 in RSV-associated disease is clearly complicated, as multiple studies in human infants have concluded that IL-17 expression negatively correlates with disease severity [30, 34, 39], suggesting that it may play a role in defense against severe RSV-associated bronchiolitis. This evidence concerns the gene IL17A and bronchiolitis.